Search Results - "Hunt, Hazel"
-
1
The glucocorticoid receptor modulator relacorilant reverses the immunosuppressive effects of cortisol
Published in International immunopharmacology (01-07-2023)“…Graphical abstract created with BioRender.com [Display omitted] •Both exogenous and endogenous glucocorticoids are immunosuppressive.•We studied the effects of…”
Get full text
Journal Article -
2
Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells
Published in Oncotarget (22-06-2021)“…BACKGROUNDResistance to antiproliferative chemotherapies remains a significant challenge in the care of patients with solid tumors. Glucocorticoids, including…”
Get full text
Journal Article -
3
Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects: A Proof-of-Concept Study
Published in Journal of clinical psychopharmacology (01-11-2021)“…Antipsychotic medications, including olanzapine, are associated with substantial weight gain and metabolic disturbances. We sought to determine whether…”
Get full text
Journal Article -
4
Peripheral glucocorticoid receptor antagonism by relacorilant with modest HPA axis disinhibition
Published in Journal of endocrinology (01-02-2023)“…Glucocorticoid stress hormones are produced in response to hypothalamic–pituitary–adrenal (HPA) axis activation. Glucocorticoids are essential for physiology…”
Get full text
Journal Article -
5
Identification of the Clinical Candidate (R)‑(1-(4-Fluorophenyl)-6-((1-methyl‑1H‑pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro‑1H‑pyrazolo[3,4‑g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist
Published in Journal of medicinal chemistry (27-04-2017)“…The nonselective glucocorticoid receptor (GR) antagonist mifepristone has been approved in the U.S. for the treatment of selected patients with Cushing’s…”
Get full text
Journal Article -
6
Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals
Published in The Journal of clinical investigation (01-08-2015)“…Alcoholism, or alcohol use disorder, is a major public health concern that is a considerable risk factor for morbidity and disability; therefore, effective…”
Get full text
Journal Article -
7
An In Vitro and In Vivo Evaluation of the Effect of Relacorilant on the Activity of Cytochrome P450 Drug Metabolizing Enzymes
Published in Journal of clinical pharmacology (01-02-2021)“…Relacorilant is a selective modulator of the glucocorticoid receptor in development for the treatment of several serious diseases. The widely used cocktail…”
Get full text
Journal Article -
8
Glucocorticoid receptor modulators decrease alcohol self-administration in male rats
Published in Neuropharmacology (01-05-2021)“…Alcohol use disorder (AUD) is associated with the dysregulation of brain stress and reward systems, including glucocorticoid receptors (GRs). The mixed…”
Get full text
Journal Article -
9
Selection and early clinical evaluation of the brain‐penetrant 11β‐hydroxysteroid dehydrogenase type 1 (11β‐HSD1) inhibitor UE2343 (Xanamem™)
Published in British journal of pharmacology (01-03-2017)“…Background and Purpose Reducing glucocorticoid exposure in the brain via intracellular inhibition of the cortisol‐regenerating enzyme 11β‐hydroxysteroid…”
Get full text
Journal Article -
10
Insights into the Therapeutic Potential of Glucocorticoid Receptor Modulators for Neurodegenerative Diseases
Published in International journal of molecular sciences (20-03-2020)“…Glucocorticoids are crucial for stress-coping, resilience, and adaptation. However, if the stress hormones become dysregulated, the vulnerability to…”
Get full text
Journal Article -
11
Selective Glucocorticoid Receptor Antagonist CORT125281 Activates Brown Adipose Tissue and Alters Lipid Distribution in Male Mice
Published in Endocrinology (Philadelphia) (01-01-2018)“…Abstract Glucocorticoids influence a wide range of metabolic processes in the human body, and excessive glucocorticoid exposure is known to contribute to the…”
Get full text
Journal Article -
12
Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator
Published in Proceedings of the National Academy of Sciences - PNAS (07-05-2013)“…Glucocorticoid receptor (GR) antagonism may be of considerable therapeutic value in stress-related psychopathology such as depression. However, blockade of all…”
Get full text
Journal Article -
13
1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile
Published in Bioorganic & medicinal chemistry letters (15-12-2015)“…[Display omitted] We report the further optimization of our series 1H-pyrazolo[3,4-g]hexahydro-isoquinoline sulfonamides as GR antagonists. By incorporating a…”
Get full text
Journal Article -
14
Identification of an acute functional cross-talk between amyloid-β and glucocorticoid receptors at hippocampal excitatory synapses
Published in Neurobiology of disease (01-10-2018)“…Amyloid-β is a peptide released by synapses in physiological conditions and its pathological accumulation in brain structures necessary for memory processing…”
Get full text
Journal Article -
15
Effects of selective and non-selective glucocorticoid receptor II antagonists on rapid-onset diabetes in young rats
Published in PloS one (18-03-2014)“…The blockade of glucocorticoid (GC) action through antagonism of the glucocorticoid receptor II (GRII) has been used to minimize the undesirable effects of…”
Get full text
Journal Article -
16
An integrated framework for quantifying immune-tumour interactions in a 3D co-culture model
Published in Communications biology (24-06-2021)“…Investigational in vitro models that reflect the complexity of the interaction between the immune system and tumours are limited and difficult to establish…”
Get full text
Journal Article -
17
Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat
Published in Bioorganic & medicinal chemistry letters (15-12-2012)“…This manuscript reports the identification of a potent, selective GR antagonist with oral bioavailability. CORT118335 exhibited excellent efficacy at a low…”
Get full text
Journal Article -
18
Azepines and Piperidines with Dual Norepinephrine Dopamine Uptake Inhibition and Antidepressant Activity
Published in ACS medicinal chemistry letters (10-01-2013)“…Herein, we describe the discovery of inhibitors of norepinephrine (NET) and dopamine (DAT) transporters with reduced activity relative to serotonin…”
Get full text
Journal Article -
19
FKBP5 mRNA Expression Is a Biomarker for GR Antagonism
Published in The journal of clinical endocrinology and metabolism (01-11-2016)“…Context: Endogenous Cushing's syndrome is caused by chronically elevated levels of cortisol. Mifepristone, a glucocorticoid receptor (GR) antagonist, is…”
Get full text
Journal Article -
20